The Valley Desk

ArticleNature medicinePublished

Normalized membrane ratio of TROP2 as a predictor of clinical outcomes with datopotamab deruxtecan in non-small-cell lung cancer

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names GSK. Affiliation source

Institution
GSK

Publication record

Type
Article
Venue
Nature medicine
Published
PubMed ID
43015400
Added to directory
Source checked

Report a correction or request removal